Lab Reagents
Breast Assay Laboratories manufactures the recurral index breast prognostic assay reagents distributed by Genprice. The Recurral Index Breast Prognostic Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact breast assay. Other Recurral products are available in stock. Specificity: Recurral Category: Index Group: Breast Prognostic
Breast Prognostic information
VAHTS Small RNA Index Primer Kit for Illumina |
|
N814 |
Vazyme |
48 rxn |
EUR 216 |
VAHTS Small RNA Index Primer Kit for Illumina |
|
N815 |
Vazyme |
48 rxn |
EUR 216 |
VAHTS Small RNA Index Primer Kit for Illumina |
|
N816 |
Vazyme |
48 rxn |
EUR 216 |
20-Place Cardboard Slide Mailer w/Index Sheet |
|
LC7001-010 |
GenDepot |
10/Pk |
EUR 151 |
20-Place Cardboard Slide Mailer w/Index Sheet |
|
LC7001-040 |
GenDepot |
40/CS |
EUR 340 |
Human Breast CAFs |
|
CAF06 |
Neuromics |
1,000,000 cells |
EUR 2732 |
Breast Cancer Exosome |
|
P141-BR |
101Bio |
NULL |
EUR 0 |
VAHTS Dual Index UMI DNA Adapters set 1 for Illumina |
|
N331 |
Vazyme |
20 μl each |
EUR 1102 |
VAHTS Dual Index UMI DNA Adapters set 2 for Illumina |
|
N332 |
Vazyme |
20 μl each |
EUR 1102 |
VAHTS Dual Index UMI DNA Adapters set 3 for Illumina |
|
N333 |
Vazyme |
20 μl each |
EUR 1102 |
VAHTS Dual Index UMI DNA Adapters set 4 for Illumina |
|
N334 |
Vazyme |
20 μl each |
EUR 1102 |
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|
BNC552552-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF555 conjugate, Concentration: 0.1mg/mL |
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|
BNC552552-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF555 conjugate, Concentration: 0.1mg/mL |
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|
BNC612552-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF660R conjugate, Concentration: 0.1mg/mL |
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|
BNC612552-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF660R conjugate, Concentration: 0.1mg/mL |
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|
BNC402552-100 |
Biotium |
100uL |
EUR 233 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF640R conjugate, Concentration: 0.1mg/mL |
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody |
|
BNC402552-500 |
Biotium |
500uL |
EUR 545 |
|
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF640R conjugate, Concentration: 0.1mg/mL |
